We are live on ! Find out more

Shoulder Innovations Inc

SI

Market cap $449M

21.46 USD

+0.92

4.48%

At close Updated Nov 9, 4:00 PM EST

1 day

4.48%

5 days

10.85%

1 month

18.37%

3 months

3.42%

6 months

62.33%

Year to date

49.34%

1 year

94.91%

5 years

42.59%

10 years

42.59%

About: Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.

Employees: 75

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 93.8%

Negative 6.3%

What Shoulder Innovations (SI) Said on Its Q3 Earnings Call

Shoulder Innovations NYSE: SI raised its full-year revenue outlook after reporting 38% growth in the third quarter, as new surgeon additions and higher use of its implants by existing customers helped offset seasonal pressure on procedures.

What Shoulder Innovations (SI) Said on Its Q3 Earnings Call

Shoulder Innovations, Inc. (SI) Q3 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Q3 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Q3 2026 Earnings Call Transcript

Zacks Investment Research

Shoulder Innovations, Inc. (SI) Reports Q3 Loss, Misses Revenue Estimates

Shoulder Innovations, Inc. (SI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to a loss of $0.48 per share a year ago.

Shoulder Innovations, Inc. (SI) Reports Q3 Loss, Misses Revenue Estimates

Shoulder Innovations Reports Third Quarter 2026 Financial Results and Raises Full Year Outlook

52% Year-to-Date 2026 Revenue Growth GRAND RAPIDS, Mich., Nov. 5, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the third quarter ended September 30, 2026.

Shoulder Innovations Reports Third Quarter 2026 Financial Results and Raises Full Year Outlook

COPE Health Solutions Named Finalist in CMS QualTech for Super Intelligence (SI) Solution to Expand Medicare Annual Wellness Visits

LOS ANGELES--(BUSINESS WIRE)-- #healthcareinnovation--COPE Health Solutions announced it has been selected as a finalist for QualTech, an industry event sponsored by the Centers for Medicare & Medicaid Services (CMS) through its Center for Clinical Standards and Quality (CCSQ). QualTech is designed to surface innovative technology solutions that address key healthcare quality priorities.CMS received more than 300 submissions across four QualTech opportunity areas and selected eight finalists. COPE Health Solutions.

COPE Health Solutions Named Finalist in CMS QualTech for Super Intelligence (SI) Solution to Expand Medicare Annual Wellness Visits

Shoulder Innovations to Participate in Upcoming Investor Conferences

GRAND RAPIDS, Mich., Oct. 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the following upcoming investor conferences: UBS Global Healthcare Conference Format: Fireside chatDate: Tuesday, November 10Fireside chat time: 3:30 PM – 4:05 PM EST Location: Palm Beach Gardens, FL Jefferies Global Healthcare Conference Format: Hybrid presentation & fireside chatDate: Tuesday, November 17Presentation time: 11:30 AM – 11:55 AM EST Location: London, UK Live and archived webcasts of both events will be available in the "Investor Relations" section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

Shoulder Innovations to Participate in Upcoming Investor Conferences

BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy

BlockchAIn Digital Infrastructure NYSEAMERICAN: AIB outlined a data-center development strategy centered on smaller, power-secured facilities, long-term tenant contracts and project-level financing during a presentation by CFO Jolienne Halisky.

BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategy

Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026

GRAND RAPIDS, Mich., Oct. 15, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2026 after market close on Thursday, November 5, 2026.

Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026

BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build

BlockchAIn Digital Infrastructure NYSEAMERICAN: AIB outlined its plans to develop a 50-megawatt data center project under a newly executed contract with Nebius, with management saying customer prepayments are expected to cover the company's required equity contribution to the project.

BlockchAIn Digital Infrastructure Says Nebius Prepayment Funds $800M Data Center Build

Shoulder Innovations Initiates Commercial Launch of the InSet® Go

Limited User Release of the Company's Next-Generation InSet® Glenoid Implant Follows Successful Completion of First Surgical Case GRAND RAPIDS, Mich., Oct. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has initiated a limited user release of the InSet® Go, the company's next-generation glenoid implant, for use in anatomic shoulder arthroplasty procedures.

Shoulder Innovations Initiates Commercial Launch of the InSet® Go

See News Rankings

Price charts implemented using Lightweight Charts™